Palmitoylethanolamide
|
Basic information |
| Metabolite name | Palmitoylethanolamide |
 | HMDB0002100 |
 |
C16512 |
 |
4671 |
| Synonyms | N-palmitoylethanolamine; |
| No. of studies | 12 |
|
Basic information |
| Metabolite name | Palmitoylethanolamide |
| HMDB0002100 |
|
C16512 |
|
4671 |
| Synonyms | N-palmitoylethanolamine; |
| No. of studies | 12 |
|
Relationship between Palmitoylethanolamide and depression (count: 12) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1054 | Type1 | CUMS group vs. control group | Plasma | ICR mouse | Down |
| Study M1054 | Type2 | CUMS + ChaihuYujinxiang granules group vs. CUMS group | Plasma | ICR mouse | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M160 | Type1 | CUMS group vs. control group | Adipose tissue | Sprague-Dawley rat | Down |
| Study M160 | Type2 | CUMS + CWD group vs. CUMS group | Adipose tissue | Sprague-Dawley rat | Up |
| Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M498 | Type3 | chronic tianeptine group vs. control group | Hippocampus | Wistar rat | Down |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Hippocampus | Wistar rat | Up |
| Study M498 | Type3 | chronic imipramine group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M498 | Type3 | acute escitalopram group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic tianeptine group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M498 | Type3 | acute escitalopram group vs. control group | Frontal cortex | Wistar rat | Down |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic escitalopram group vs. control group | Frontal cortex | Wistar rat | Down |
| Study M498 | Type3 | acute imipramine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic imipramine group vs. control group | Cerebellum | Wistar rat | Down |
| Study M498 | Type3 | chronic URB597 group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M498 | Type3 | chronic imipramine group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | acute imipramine group vs. control group | Hippocampus | Wistar rat | Up |
| Study M498 | Type3 | chronic URB597 group vs. control group | Cerebellum | Wistar rat | Up |
| Study M498 | Type3 | acute URB597 group vs. control group | Hippocampus | Wistar rat | Down |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Dorsal striatum | Wistar rat | Up |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M498 | Type3 | chronic N-acetylcysteine group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M498 | Type3 | chronic URB597 group vs. control group | Hippocampus | Wistar rat | Down |
| Study M498 | Type3 | acute tianeptine group vs. control group | Hippocampus | Wistar rat | Down |
| Study M500 | Type3 | repeated URB597 group vs. control group | Hippocampus | Wistar rat | Up |
| Study M500 | Type3 | single URB597 group vs. control group | Hippocampus | Wistar rat | Up |
| Study M500 | Type3 | single URB597 group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M500 | Type3 | repeated URB597 group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M500 | Type3 | repeated URB597 group vs. control group | Midbrain | Wistar rat | Up |
| Study M500 | Type3 | single URB597 group vs. control group | Midbrain | Wistar rat | Up |
| Study M503 | Type2 | SDS + URB694 group vs. SDS group | Plasma | Wistar Kyoto rat | Up |
| Study M578 | Type1 | restraint stress offspring group vs. control offspring group | Hippocampus | Sprague-Dawley rat | Down |
| Study M598 | Type1 | MS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M811 | Type2 | CUMS + middle dose of dipyrone group vs. CUMS group | Amygdala | Balb/c mouse | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Up |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
| Study M869 | Type2 | CUMS + middle dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M869 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |